Dr. Richard Spaide, MD
What this data tells you about Dr. Spaide
Dr. Richard Spaide is an optician specialist in New York, NY, with 19 years of NPI registration. Based on federal Medicare data, Dr. Spaide performed 37,194 Medicare services across 2,864 unique beneficiaries.
Between the years covered by Open Payments, Dr. Spaide received a total of $1,654,885 from 26 pharmaceutical and/or device companies across 198 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in optician. The majority of payments are classified as financial or ownership interests (royalties, licensing fees, or investment interests). Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Spaide is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
Medicare Practice Summary
Medicare Utilization ↗Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Eye injection (Vabysmo/faricimab) An injection of faricimab-svoa, a medication administered in 0.1 mg doses. |
30,420 | $29 | $38 |
| Retinal imaging (OCT scan) This procedure involves imaging the retina to visualize its structure. It is used to examine the back of the eye. |
1,682 | $35 | $64 |
| Eye exam, established patient, focused A limited examination of the visual system for an existing patient. The provider focuses on a specific eye-related concern or symptom. |
1,123 | $78 | $132 |
| Eye injection for retinal disease A procedure involving the administration of medication directly into the eye. |
908 | $112 | $520 |
| Aflibercept eye injection (Eylea) | 870 | $692 | $919 |
| Retinal photography (fundus photo) This procedure involves taking photographs of the retina, the light-sensitive tissue at the back of the eye. It is used to document the condition of the eye's interior structures. |
685 | $33 | $64 |
| Injection, ranibizumab, 0.1 mg | 447 | $182 | $270 |
| Comprehensive eye exam, established patient A comprehensive examination of the visual system performed for a patient who has previously been seen by the provider. |
415 | $105 | $170 |
| Extended exam of back of eye with optic nerve drawing A detailed examination of the posterior section of the eye, including the optic nerve, with documentation through drawing. |
394 | $14 | $49 |
| Comprehensive eye exam, new patient A comprehensive examination of the visual system performed for a new patient. |
147 | $123 | $475 |
| Ultrasound of eye tissue and structures A diagnostic imaging test that uses sound waves to create pictures of the eye's internal tissues and structures. |
36 | $46 | $107 |
| Visual field test, extended A test that maps your complete field of vision to detect blind spots or peripheral vision loss. Extended testing provides a more detailed assessment than a standard visual field exam. |
27 | $59 | $104 |
| Extended eye exam with retinal drawing A detailed examination of the back of the eye that includes creating a drawing of the retina. |
23 | $21 | $42 |
| Retinal angiography with dye injection This procedure uses a special camera to examine the blood vessels in the retina after a dye has been injected into the body. |
17 | $130 | $194 |
Industry Payment Transparency
Open Payments through 2024 ↗Payment profile
Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
Payments by company (2024)
All-time payments by company (2018-2024) ›
Associated products mentioned in payments ›
Payments are distributed across multiple categories with no single dominant type. Total industry engagement is in the top 0% for optician in NY.
Geographic Context
0.5 mi
Data Sources
| Provider Registry | ✓ NPPES | Weekly updates |
| Medicare Enrollment | ✓ PECOS | Monthly updates |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not public | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →
Summary
Dr. Spaide is a mixed practice specialist, with above-average Medicare volume (top 2% in NY), with mixed engagement industry engagement in the top 0% of NY peers, with 19 years of NPI registration.
This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →
Frequently Asked Questions
Is Dr. Spaide experienced with eye injection (vabysmo/faricimab)?
Does Dr. Spaide receive payments from pharmaceutical companies?
How do Dr. Spaide's costs compare to other opticians in New York?
What does Data Coverage mean?
Is this data up to date?
Explore related providers
All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology